Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics
Volume 10, Issue 4, July 2023, Pages 1367-1401
The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases
Volume 8, Issue 3, May 2021, Pages 287-297
Age-related macular degeneration: Epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy
Volume 9, Issue 1, January 2022, Pages 62-79
CCL5/CCR5 axis in human diseases and related treatments
Volume 9, Issue 1, January 2022, Pages 12-27
The biogenesis and secretion of exosomes and multivesicular bodies (MVBs): Intercellular shuttles and implications in human diseases
Volume 10, Issue 5, September 2023, Pages 1894-1907
Targeting RAS–RAF–MEK–ERK signaling pathway in human cancer: Current status in clinical trials
Volume 10, Issue 1, January 2023, Pages 76-88
Critical roles of FTO-mediated mRNA m6A demethylation in regulating adipogenesis and lipid metabolism: Implications in lipid metabolic disorders
Volume 9, Issue 1, January 2022, Pages 51-61
Canonical and noncanonical Wnt signaling: Multilayered mediators, signaling mechanisms and major signaling crosstalk
Volume 11, Issue 1, January 2024, Pages 103-134
HIF-1α signaling: Essential roles in tumorigenesis and implications in targeted therapies
Volume 11, Issue 1, January 2024, Pages 234-251
Wnt signaling: Essential roles in osteoblast differentiation, bone metabolism and therapeutic implications for bone and skeletal disorders
Volume 10, Issue 4, July 2023, Pages 1291-1317
NADPH debt drives redox bankruptcy: SLC7A11/xCT-mediated cystine uptake as a double-edged sword in cellular redox regulation
Volume 8, Issue 6, November 2021, Pages 731-745
Molecular subtypes of colorectal cancer: An emerging therapeutic opportunity for personalized medicine
Volume 8, Issue 2, March 2021, Pages 133-145
The critical roles of m6A modification in metabolic abnormality and cardiovascular diseases
Volume 8, Issue 6, November 2021, Pages 746-758
Oridonin and its derivatives for cancer treatment and overcoming therapeutic resistance
Volume 8, Issue 4, July 2021, Pages 448-462
A new emerging target in cancer immunotherapy: Galectin-9 (LGALS9)
Volume 10, Issue 6, November 2023, Pages 2366-2382
Cancer: An unknown territory; rethinking before going ahead
Volume 8, Issue 5, September 2021, Pages 655-661
Cancer cell cycle heterogeneity as a critical determinant of therapeutic resistance
Volume 11, Issue 1, January 2024, Pages 189-204
Non-small cell lung carcinoma (NSCLC): Implications on molecular pathology and advances in early diagnostics and therapeutics
Volume 10, Issue 3, May 2023, Pages 960-989
Mitochondrial dysfunction: A promising therapeutic target for liver diseases
Volume 11, Issue 3, May 2024, Page
Targeting LIF/LIFR signaling in cancer
Volume 9, Issue 4, July 2022, Pages 973-980
Regulation of ferroptosis in cancer cells by YAP/TAZ and Hippo pathways: The therapeutic implications
Volume 8, Issue 3, May 2021, Pages 241-249
Inflammation and cancer: paradoxical roles in tumorigenesis and implications in immunotherapies
Volume 10, Issue 1, January 2023, Pages 151-164
Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicine
Volume 11, Issue 1, January 2024, Pages 268-282
Pretreating and normalizing metabolomics data for statistical analysis
Volume 11, Issue 3, May 2024, Page
Ribonucleotide reductase M2 (RRM2): Regulation, function and targeting strategy in human cancer
Volume 11, Issue 1, January 2024, Pages 218-233
